- ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease
This study is looking into a new medication called TEV-53408 for adults with coeliac disease. It's an early-stage trial focusing on making sure the medication is safe and can be handled well by the body, rather than how well it treats the condition.
Finland - ongoing, recruitingTherapeutic exploratory (Phase II)
KAN-101-03: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease
This study is testing a new medicine, KAN-101, for people with coeliac disease. It wants to see if the medicine can help the gut lining heal and reduce symptoms, and if it's safe to use. Patients will receive either the medicine or a dummy treatment.
Finland · Ireland · Poland - active not recruitingPHASE2
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
This study is testing a new medicine, amlitelimab, for adults with coeliac disease that isn't getting better with a gluten-free diet. It looks at how well the medicine works and if it's safe, by checking changes in the gut and how people feel.
United States · Argentina · Australia - recruiting
Pathogenic Study of Adult Immune Enteropathies
This study looks into why certain gut conditions, like coeliac disease and inflammatory bowel diseases, happen. Researchers want to understand how the immune system in the gut goes wrong and how it might lead to other problems, including those affecting the liver.
France - recruitingNA
Tryptophan for Impaired AhR Signaling in Celiac Disease
This study looks at whether a supplement called L-tryptophan can help people with coeliac disease whose symptoms haven't improved on a gluten-free diet. We want to see if it makes a difference to their gut health and symptoms.
Canada